Compare OPK & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPK | OCSL |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2011 | 2007 |
| Metric | OPK | OCSL |
|---|---|---|
| Price | $1.38 | $12.98 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $1.60 | ★ $12.63 |
| AVG Volume (30 Days) | ★ 4.4M | 535.1K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 12.73% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $606,879,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.24 | $0.31 |
| P/E Ratio | ★ N/A | $65.30 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $10.63 |
| 52 Week High | $1.73 | $14.31 |
| Indicator | OPK | OCSL |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 65.22 |
| Support Level | $1.27 | $12.31 |
| Resistance Level | $1.41 | $13.19 |
| Average True Range (ATR) | 0.09 | 0.31 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 23.33 | 93.59 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.